Biolux Technology and Dentli have entered a partnership aimed at helping orthodontic practices attract patients through combined use of OrthoPulse and targeted marketing services.
The company will showcase OrthoPulse and its Light Accelerated Orthodontics technology at a number of trade shows and meetings this fall in North America and Europe.
Align Technology’s Srini Kaza details how large-scale and direct 3D printing are reshaping orthodontic care and what private practices can expect in the back half of 2025.
Biolux Research’s latest product, OrthoPulse, was approved as a Class 2 medical device by Health Canada.
Read More
Biolux Research plans to release the OrthoPulse device, which uses photobiomodulation to reduce orthodontic treatment time, in the United States in early 2015, once FDA clearance is obtained.
Read More
Forty-four Schulman members will evaluate OrthoPulse, an intraoral device that incorporates proprietary photobiomodulation technology and is designed to be used with any form of orthodontic mechanics to significantly reduce patient treatment timelines, in their practices.
Read More
The joint venture will bring about the manufacture and commercialization of the OrthoPulse accelerated tooth movement technology.
Read More
Combining clear aligners and the intraoral Biolux technology, patients may be able to achieve both cosmetic benefit and reductions in treatment timeline.
Read More
As VP of Global Sales and Marketing, Nabors will be responsible for the commercialization of the company’s OrthoPulse technology.
Read More